Strengthening and diversifying product portfolio drives M&A activity
Witnesses one deal during December 2013
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
’Biotech for a Better Tomorrow’ key theme at Bangalore India Bio
Delegations from various countries are expected, with key participation from the European Union, Scotland and the Czech Republic
What’s in the cards for 2014?
Most pharma leaders want to bid adieu to annus horribilis 2013 and ring in the new year with renewed focus and vigour. What's on…
’India is one of the focussed countries for Menarini in terms of investment’
Girdhar Balwani, Managing Director, Menarini India, speaks to Viveka Roychowdhury on the company’s strategy to strengthen its…
Lilly enters branded generics market with launch of Lil Therapeutics
Announces launch of drugs in breast cancer and colo-rectal cancer segment
Indegene and DrugLogic to offer full lifecycle drug monitoring
To help for insightful analysis of drug behaviour, interactions, and safety
Merck signs license agreement with CNIO
New agreement aims to translate CNIO research into new potential treatment options for cancer patients
Biocon inks licensing pact with US-based Quark Pharma
To develop a range of siRNA based novel therapeutics
GSK to increase stake in its pharmaceuticals subsidiary in India
Offer to start from February 7 and close on February 22
Torrent to buy Elders branded formulations biz
To fund acquisition through mix of internal accruals, bank borrowings
IPM clocks Rs 6291 crores in November 2013
After three continuous months of volume degrowth, market sees seasonal change
65th IPC: More power to the pharmacist
The pharmacist stood at the centre of the three-day event that witnessed scientific symposia, poster presentations, a job fair and…
BD Medical – Pharmaceutical Systems organises Technovation seminar for pharma cos
Seminar addresses challenges faced by manufacturers in their endeavour to reach global markets
’India will become free from NTDs by 2020’
India is in a position to elevate Neglected Tropical Diseases (NTDs) and build awareness on how their control and elimination will…
Strides Arcolab completes sale of Agila Specialties division to Mylan
$250 million to be payable upon satisfaction of certain regulatory conditions
UK partners with BioAsia as principal country partner
Partners with BioAsia as principal country partner
Jubilant Life Sciences receives ANDA approval for Quetiapine Fumarate tablets
Is indicated for the treatment of schizophrenia, and for the treatment of acute manic episodes associated with bipolar disorder